Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/23/22 10:58 | 9/22/22 | ETON | Health | Drug | Pharmaceutical Preparations | Brynjelsen Sean | IL | DO | CEO | P | 21 | 2.10 | 0 | 10 | 1 | 1,065 | D | ||||||||||||||
11/19/21 16:09 | 11/17/21 | ETON | Health | Drug | Pharmaceutical Preparations | Opaleye Management Inc. | MA | T | S | -117 | 4.67 | 0 | -25 | -1 | 2,375 | I | |||||||||||||||
11/17/21 16:33 | 11/15/21 | ETON | Health | Drug | Pharmaceutical Preparations | Opaleye Management Inc. | MA | T | S.m | -75 | 4.85 | 0 | -15 | -1 | 2,485 | I | |||||||||||||||
11/9/21 16:46 | 11/5/21 | ETON | Health | Drug | Pharmaceutical Preparations | Opaleye Management Inc. | MA | T | S.m | -1,378 | 6.25 | 0 | -220 | -8 | 2,500 | I | |||||||||||||||
11/5/21 16:13 | 11/3/21 | ETON | Health | Drug | Pharmaceutical Preparations | Opaleye Management Inc. | MA | T | S.m | -1,313 | 6.49 | 0 | -202 | -7 | 2,721 | I | |||||||||||||||
10/13/21 07:57 | 10/8/21 | ETON | Health | Drug | Pharmaceutical Preparations | Opaleye Management Inc. | MA | T | S.m | -831 | 5.03 | 0 | -165 | -5 | 2,932 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |